Colostrum

Colostrum (foremilk) is the first secretion of the mammary gland (breast) produced before proper lactation commences in a nursing mother. It is the first breast milk produced from the mammary gland or breast of a woman after giving birth to a baby. It is a major source of passive immunity transferred from mother to the newborn child; and colostrum confers several health benefits to the newborn inclusive of growth factors or nutrients aside its protective function in the immune system of the host.

Colostrum is a specialized biological secretion produced by the mammary glands of mammals during late pregnancy and the initial period following childbirth. Commonly described as the first milk, it represents a distinct stage of lactation characterized by a concentrated composition of nutritional, immunological and bioactive constituents. Unlike mature milk, which primarily sustains ongoing growth and nutritional requirements, colostrum is particularly adapted to the physiological demands of the newborn during the critical transition from intrauterine to extrauterine life.

Its production reflects an evolutionary adaptation that enables maternal organisms to provide their offspring with essential substances required for early development and protection. Following parturition (childbirth or labour), colostrum becomes the newborn’s first source of externally derived nourishment and biological defense. Although its secretion occurs in relatively small volumes, its composition is remarkably dense, containing proteins, immunoglobulins, vitamins, minerals, growth factors, enzymes and other functional molecules.

These constituents collectively contribute to the establishment of essential physiological processes, including metabolic regulation, gastrointestinal maturation and immune competence. Of particular significance are immunoglobulins, which provide passive immune protection by transferring maternal antibodies to the offspring. This mechanism is especially important because newborns generally possess an immature immune system and may have limited capacity to mount effective responses against environmental pathogens immediately after birth.

Colostrum serves not merely as an initial nutritional source but also as a fundamental mediator of neonatal adaptation and survival. The biological significance of colostrum is further demonstrated by its distinctive composition in comparison with mature breast milk. Colostrum generally contains higher concentrations of total protein, immunoglobulins, lactoferrin and several growth-promoting factors, whereas mature milk is relatively richer in fat and lactose, supporting the increasing energy requirements associated with sustained growth.

The elevated protein concentration in colostrum is largely attributable to its abundance of immune-related proteins and other functional components rather than serving exclusively as an energy source. Colostrum contains vitamins and minerals that contribute to early metabolic and developmental requirements. Its characteristic yellowish appearance and relatively viscous consistency are associated with its concentrated composition, although these characteristics may vary among individuals and mammalian species.

The transition from colostrum to mature milk is a gradual physiological process influenced by hormonal regulation and changes in mammary gland activity. In humans, colostrum is generally secreted during the first few days following delivery before progressively transitioning into transitional and subsequently mature milk. This temporal progression reflects changing neonatal requirements, with early lactation prioritizing immune protection and physiological adaptation, followed by sustained nutritional support.

Colostrum should be understood as a specialized and biologically indispensable component of early mammalian development, establishing the nutritional and immunological foundations necessary for the newborn’s initial stages of independent life. As aforesaid, colostrum is generally the first milk produced from a female animal inclusive of humans after 48 hours of delivery; and this milk is characteristically thick and yellowish in colouration. The main immunoglobulin molecule found in the colostrum is secretary immunoglobulin A (sIgA).

After birth, the newborn is exposed to plethora of microorganisms in the environment including those acquired from the vagina or birth canal of the mother. Since the immune system of the infant is not well developed and strong to fight against pathogens, it is the immunologic defense provided by the colostrum that help to protect the child from harmful activities of microbes it comes in contact with. Though this type of immunity is passive in nature and does not last long; it serves as the major basis for the development of the newborn’s own immune system at a later stage in life.

The production of colostrum in the mammary gland of humans and other animals usually continues through the early few days or weeks of delivery after its production in the last phase of pregnancy or after delivery. Nevertheless, the production of colostrum lasts for about 2-4 days after the lactation phase has begun in the mother. It is advisable according the World Health Organization (WHO) that mothers should ensure that their newborns have unrestricted access to this milk.

According to WHO, breastfeeding should be “exclusive” since the breast milk from the mammary gland contains the major nutritive requirement for the development of the child inclusive of water for about 6 months. However, this practice of “exclusive breast feeding” is not evenly practiced in some cultures due to some religious, occupational and cultural believe of some ethnicity. Colostrum is rich in carbohydrates, amino acids, proteins, and antibodies; and it is generally low in fats. It is also rich in vitamins and other minor and major minerals required keeping the newborn healthy.

Colostrum gives a general immunity (though passive in nature) to the newborn from the mucous membrane of the mouth or throat, down to the lungs and even the gastrointestinal tract (GIT) – where it protects the infant from some GIT-related microbial infections such as diarrhea. Breast milk is still the safest and healthiest from of food for a newborn; and it is advisable that mothers exclusively breast feed their babies for six months after which they can be weaned and given other forms of food.         

Composition and nutritional value of colostrum

Colostrum is a complex biological secretion characterized by a distinctive nutritional and biochemical profile that differentiates it from mature breast milk. Produced in the mammary glands during late pregnancy and secreted during the initial days following childbirth, colostrum provides a highly concentrated source of nutrients and biologically active molecules essential for neonatal adaptation, growth, and physiological development. Although its production occurs in relatively small volumes, its composition is particularly rich in proteins, immunological factors, vitamins, minerals, and other functional constituents that collectively support the newborn during the critical transition from intrauterine to extrauterine life.

One of the most prominent characteristics of colostrum is its elevated protein concentration. These proteins comprise not only nutritional components required for tissue synthesis and cellular development but also specialized proteins involved in immune protection and physiological regulation. Immunoglobulins represent a particularly important fraction, with immunoglobulin A (IgA) playing a significant role in mucosal defense. Secretory IgA contributes to the protection of the gastrointestinal and respiratory mucosal surfaces by limiting pathogen attachment and penetration.

Other immunoglobulins, including IgG and IgM, further contribute to the immunological properties of colostrum. In addition, proteins such as lactoferrin and lysozyme exhibit antimicrobial activities, supporting the establishment of protective mechanisms during early neonatal development. Beyond its protein content, colostrum contains a diverse array of vitamins and minerals that contribute to metabolic activity and physiological homeostasis. Fat-soluble vitamins, particularly vitamins A and E, are important for epithelial integrity, visual development, and antioxidant protection.

Vitamin D contributes to calcium regulation and skeletal development, while water-soluble vitamins participate in enzymatic reactions and energy metabolism. Mineral constituents, including calcium, phosphorus, zinc, iron, and magnesium, support bone formation, cellular function, enzymatic activity, and the development of essential physiological systems. Their presence contributes to meeting the newborn’s nutritional requirements during the initial postnatal period.

Another defining feature of colostrum is the presence of bioactive compounds, including growth factors, cytokines, enzymes, and regulatory peptides. Growth factors, such as epidermal growth factor (EGF) and insulin-like growth factors (IGFs), are associated with intestinal epithelial maturation, tissue repair, and cellular proliferation. These compounds may facilitate gastrointestinal development and support the functional adaptation of the digestive tract. Enzymes also contribute to nutrient processing and biological defense, while cytokines participate in the regulation of immune responses and inflammatory processes.

Compared with mature breast milk, colostrum generally contains higher concentrations of protein and several micronutrients, whereas its fat and lactose concentrations are comparatively lower. This compositional distinction reflects the specific physiological demands of the newborn during the immediate postnatal period. Its relatively low volume and concentrated nutrient density make colostrum particularly suited to the limited digestive capacity of the neonatal gastrointestinal tract.

Immune system benefits of colostrum

Colostrum plays a fundamental role in establishing immune protection during the early stages of life, when newborns have an immature immune system and limited capacity to defend themselves against infectious agents. As the first secretion of the mammary glands following childbirth, colostrum provides a concentrated supply of immunological components that contribute to the development of the newborn’s natural defence mechanisms. Its protective properties are particularly important during the neonatal period, when exposure to bacteria, viruses and other environmental pathogens presents a significant health challenge.

One of the most important immunological functions of colostrum is the transfer of passive immunity. This protection is primarily mediated by immunoglobulins, particularly immunoglobulin A (IgA), immunoglobulin G (IgG) and immunoglobulin M (IgM). These antibodies recognize and bind to specific antigens, helping neutralise pathogens and prevent their attachment to mucosal surfaces. In human colostrum, secretory IgA is especially abundant and contributes to the protection of the gastrointestinal and respiratory tracts.

In contrast, bovine colostrum contains particularly high concentrations of IgG, which is essential for systemic passive immune protection in calves because the bovine placenta allows very little maternal antibody transfer before birth. Beyond antibody-mediated protection, colostrum contains several bioactive substances that contribute to innate immune defense. Lactoferrin, lysozyme and lactoperoxidase are important antimicrobial components that help restrict microbial growth through different biological mechanisms.

Lactoferrin, for example, limits bacterial proliferation by binding iron, an essential nutrient required by many microorganisms. Lysozyme contributes to bacterial cell-wall disruption, while other antimicrobial peptides help strengthen the body’s initial defense against invading pathogens. Together, these substances create a protective biological environment that reduces the vulnerability of newborns to early infections. Colostrum also contributes to immune system development by supporting communication between immune cells and regulating inflammatory responses.

Cytokines, growth factors and other immunomodulatory molecules present in colostrum participate in the coordination of immune activity. Rather than simply stimulating immune responses, these components help maintain an appropriate balance between protective inflammation and immune tolerance. This regulation is important because excessive inflammatory reactions can damage developing tissues, whereas insufficient immune responses may increase susceptibility to infection.

The immunological benefits of colostrum are closely associated with gastrointestinal health. By supporting intestinal barrier integrity and influencing the establishment of beneficial gut microorganisms, colostrum helps create conditions that favour immune maturation. The intestinal tract represents a major interface between the external environment and the developing immune system, making its protection particularly significant during early life.

Colostrum functions as a complex biological source of passive immune protection and immunomodulatory activity. Its antibodies, antimicrobial proteins and regulatory molecules work through complementary mechanisms to protect newborns while supporting the gradual maturation of their own immune defences. The effectiveness of this protection depends on species-specific differences in placental antibody transfer, the composition of colostrum and the timing of its intake after birth.

Role of colostrum in gastrointestinal development and early-life intestinal adaptation

Colostrum plays a fundamental role in the establishment and functional maturation of the neonatal gastrointestinal tract. As the first biological secretion produced by the mammary gland following parturition, it delivers a concentrated combination of bioactive molecules that contribute to intestinal development, epithelial integrity, digestive function, and microbial colonisation. Beyond providing essential nutrients, colostrum acts as a signalling medium that facilitates the transition of the gastrointestinal system from its intrauterine environment to extrauterine feeding and digestion.

One of the principal contributions of colostrum is its influence on intestinal epithelial development. Its composition includes growth factors, cytokines, immunoglobulins, lactoferrin, and other biologically active compounds that interact with intestinal cells. These components support epithelial cell proliferation, differentiation, and the development of the intestinal mucosal barrier. Improved epithelial integrity is particularly important during the neonatal period, when the gastrointestinal tract is still developing and remains susceptible to environmental antigens, microbial invasion, and inflammatory disturbances.

By supporting mucosal maturation, colostrum contributes to the establishment of an effective protective interface between the intestinal lumen and the internal environment. Colostrum also contributes to the early establishment of the gut microbiome. The neonatal intestine undergoes rapid microbial colonisation following birth, with initial microbial populations influencing subsequent gastrointestinal and immune development.

Bioactive constituents of colostrum, including human milk oligosaccharides and other complex carbohydrates, can selectively support beneficial bacterial populations, particularly members of the Bifidobacterium genus. This selective microbial enrichment contributes to the development of a balanced intestinal ecosystem, promotes microbial diversity, and influences the production of metabolites involved in intestinal homeostasis. Antimicrobial components such as lactoferrin and immunoglobulins help regulate microbial growth and interactions within the intestinal environment.

Another important function of colostrum involves supporting gastrointestinal motility and the early development of digestive activity. Its bioactive constituents facilitate intestinal adaptation to enteral nutrition and contribute to the development of physiological processes necessary for nutrient digestion and absorption. The coordinated maturation of intestinal tissues and digestive functions enables newborns to progressively adapt to milk consumption as their primary source of nutrition.

Colostrum facilitates the passage of meconium, the dark, viscous first intestinal content accumulated during fetal development. Early meconium evacuation is an important physiological event because it assists in clearing intestinal contents and initiating normal postnatal bowel function. Colostrum intake stimulates gastrointestinal activity and provides the fluid and nutritional components necessary to support this process. In particular, early and frequent feeding helps promote intestinal transit and facilitates the transition towards regular stool production.

These biological activities demonstrate that colostrum is not merely an initial nutritional supply but also an important regulator of early gastrointestinal adaptation. Through its combined effects on epithelial maturation, mucosal protection, microbial colonization, and intestinal motility, colostrum helps establish the structural and functional foundations required for healthy digestive development during the neonatal period.

Colostrum production and secretion

Colostrum production is a highly coordinated physiological process that begins during pregnancy and undergoes substantial changes following childbirth. Its synthesis is regulated by hormonal signals, mammary gland development, and the metabolic adaptations associated with late gestation and the onset of lactation. During pregnancy, the mammary glands undergo structural and functional modifications that prepare them for milk secretion. Under the influence of hormones such as prolactin, progesterone, oestrogen, and human placental lactogen, mammary epithelial cells differentiate into secretory cells capable of synthesizing colostrum.

Although prolactin stimulates milk synthesis, elevated progesterone concentrations during pregnancy inhibit substantial milk secretion, allowing colostrum to accumulate within the mammary alveoli. Following delivery, the expulsion of the placenta results in a rapid decline in circulating progesterone levels. This hormonal withdrawal, together with sustained prolactin activity, initiates secretory activation, commonly referred to as lactogenesis II. Consequently, the mammary glands increase their secretory activity, supporting the transition from the prenatal accumulation of colostrum to active milk production.

Colostrum is generally secreted during the first two to four days after childbirth, although the precise duration varies between individuals and may be influenced by maternal physiological conditions, gestational age, and delivery-related factors. Unlike mature breast milk, colostrum is produced in relatively small volumes. This limited secretion is physiologically appropriate because the newborn’s stomach has a relatively small capacity during the initial postnatal period. Despite its modest volume, colostrum provides a concentrated source of immunological and nutritional components that support neonatal adaptation to extrauterine life.

Its secretion occurs frequently in response to early breastfeeding, with newborns typically receiving small quantities through repeated feeding episodes. The progression from colostrum to transitional milk represents a dynamic modification in mammary secretory activity rather than an abrupt change in composition. As lactation advances, milk volume progressively increases, while the concentrations of several immune-associated proteins and other bioactive constituents change. This transition reflects the evolving nutritional and developmental requirements of the growing infant.

By approximately two weeks postpartum, breast milk generally acquires the characteristics of mature milk, although compositional changes continue throughout lactation. Milk production is also governed by local regulatory mechanisms within the mammary gland. Frequent breastfeeding and effective milk removal stimulate continued synthesis by reducing the accumulation of locally acting inhibitory factors within the breast.

Prolonged intervals between feeds or inadequate milk removal may suppress subsequent milk production. Suckling additionally stimulates the release of oxytocin from the posterior pituitary gland, facilitating contraction of mammary myoepithelial cells and promoting milk ejection. Therefore, successful colostrum transfer and the establishment of sustained lactation depend on the coordinated interaction between endocrine regulation, mammary gland physiology, and effective breastfeeding practices.

Importance of colostrum for newborn health

Colostrum plays a fundamental role in establishing neonatal health, providing a biologically active source of nutrition and immune protection during the critical transition from intrauterine to extrauterine life. As the first secretion of the mammary gland following childbirth, it delivers a concentrated combination of immunological, nutritional and bioactive components that contribute to the newborn’s immediate physiological adaptation and subsequent development.

One of its most significant functions is the provision of passive immune protection. Newborns, particularly during the initial stages of life, possess an immature immune system and are consequently more susceptible to infectious agents. Colostrum supplies maternal immunoglobulins, especially IgA, alongside lactoferrin, lysozyme and other antimicrobial compounds. These constituents contribute to pathogen neutralisation, inhibit microbial proliferation and support the development of mucosal defence mechanisms. Through these protective activities, colostrum helps reduce the newborn’s vulnerability to gastrointestinal and other early-life infections.

Beyond its immunological properties, colostrum provides a highly concentrated nutritional supply adapted to the metabolic requirements of newborns. Its composition includes proteins, essential amino acids, vitamins, minerals and readily available energy sources, supporting the physiological demands associated with postnatal adaptation. The presence of bioactive molecules, including epidermal growth factor and insulin-like growth factors, further contributes to tissue maturation, cellular proliferation and the development of essential organ systems.

Colostrum is also particularly important for gastrointestinal development. Its bioactive constituents promote intestinal epithelial maturation, strengthen mucosal integrity and facilitate the establishment of a functional intestinal barrier. Furthermore, its prebiotic components contribute to the development of the intestinal microbiota, which is essential for digestive function, nutrient utilisation and immune regulation. These processes collectively establish a favourable physiological environment for healthy neonatal growth.

The benefits of colostrum are especially relevant for premature and medically vulnerable infants, whose immunological and gastrointestinal systems may be less developed at birth. Adequate colostrum exposure can provide essential protective factors during a period of heightened physiological vulnerability. Therefore, early colostrum feeding represents an important component of neonatal nutritional care, contributing not only to immediate protection but also to the foundations of long-term health and development.

Colostrum in animal health and commercial applications

Colostrum represents a critical biological resource in animal production, particularly during the early postnatal period, when newborn livestock are highly dependent on maternal-derived immune protection. In calves, the ingestion of colostrum shortly after birth is essential because the epitheliochorial structure of the bovine placenta prevents substantial prenatal transfer of maternal immunoglobulins. Calves are born with limited circulating antibodies and depend on the absorption of immunoglobulins, predominantly IgG, through the intestinal epithelium.

This process, known as passive immune transfer, provides early systemic protection against infectious agents and contributes to neonatal survival, growth performance, and overall physiological development. Beyond its immunological contribution, bovine colostrum contains a complex matrix of bioactive constituents, including lactoferrin, lysozyme, cytokines, growth factors, oligosaccharides, and antimicrobial peptides. These components participate in intestinal maturation, epithelial integrity, microbial regulation, and tissue development.

The nutritional and functional properties of colostrum have therefore attracted considerable interest in livestock nutrition, particularly in the formulation of feeding strategies designed to improve gastrointestinal health, disease resistance, and production efficiency. The commercial exploitation of bovine colostrum has expanded through the development of specialised processing and preservation technologies. Freeze-drying, spray-drying, filtration, and controlled heat treatment are employed to produce colostrum powders, concentrates, and other functional ingredients.

These processes aim to improve shelf stability, facilitate transportation, and retain selected immunological and nutritional properties. However, processing conditions require careful optimization because excessive thermal exposure may compromise the structural integrity and biological activity of sensitive proteins. In addition to its established applications in veterinary nutrition, bovine colostrum has emerged as an ingredient of interest in the human nutraceutical and functional food sectors. For example, commercial formulations increasingly incorporate colostrum-derived proteins and bioactive fractions into dietary supplements, sports nutrition products, and specialized nutritional preparations.

References

Playford, R. J., & Weiser, M. J. (2021). Bovine colostrum: Its constituents and uses. Nutrients, 13(1), 265.

Abbas A.K, Lichtman A.H and Pillai S (2010). Cellular and Molecular Immunology. Sixth edition. Saunders Elsevier Inc, USA.

Actor J (2014). Introductory Immunology. First edition. Academic Press, USA.

Barrett   J.T (1998).  Microbiology and Immunology Concepts.  Philadelphia,   PA:  Lippincott-Raven Publishers. USA.

Jaypal V (2007). Fundamentals of Medical Immunology. First edition. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India.

Levinson W (2010). Review of Medical Microbiology and Immunology. Twelfth edition. The McGraw-Hill Companies, USA.

Roitt I, Brostoff J and Male D (2001). Immunology. Sixth edition. Harcourt Publishers Limited, Spain.